• Home
  • About Us
  • Contact
  • Your Account
  • Subscribe
Friday, July 1, 2022
  • Login
Alternatives Watch
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
No Result
View All Result
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
No Result
View All Result
Alternatives Watch
No Result
View All Result

Alts Watch Healthcare Beat: DNA unicorn, Chinese healthcare portal deals shine

Susan BarretobySusan Barreto
January 4, 2021
in Manager News, Private Equity
Alts Watch Healthcare Beat: DNA unicorn, Chinese healthcare portal deals shine

By twenty20photos

ShareTweetShareSendSend

It was another short work week due to the New Year’s holiday, but there were still two deals that attracted significant capital for the week ending January 3.

The Alts Watch Healthcare Beat tracks weekly investor activity in the life sciences arena including biotech, medical devices and technology. This past week a Chinese healthcare portal raised a significant sum, while 23andMe saw another round of financing.

Below are the details on these two deals that total nearly $600 million.

DXY

  • The deal: $500 million Series E financing.
  • The players: The financing round was led by Shanghai-based Trustbridge Partners and followed by Tencent Investment and Hillhouse Capital’s early staged focused GL Ventures.
  • The play:  DXY is a digital healthcare technology company in China. Founder and Chairman of DXY Li Tiantian said that the company will, driven by both two ends — physicians and the public, strengthen collaboration with professional doctors and enterprises.

23andMe

  • The deal: Raised $85 million in December.
  • The players: Reportedly, the DNA testing company raised capital from Sequoia Capital and NewView Capital.
  • The play: The company reported that more than 80% of 23andMe’s 12 million customers have agreed to participate in drug discovery research. The company has also taken on a role in helping with COVID-19 research.
ShareTweetShareSendSend
Previous Post

Hedge funds at the ready and steady for a 2021 comeback

Next Post

VRS allocates $500m to private market funds

Related Posts

LACERA channels more money into alts
Pensions

LACERA channels more money into alts

Kentucky Teachers hands out alts assignments
Pensions

Kentucky Teachers hands out alts assignments

Red Arts Capital finds value in the supply chain
Features

Red Arts Capital finds value in the supply chain

NM fund adds over $170 million to RE and PE
Pensions

NM fund adds over $170 million to RE and PE

Hamilton Lane invests in alts RIA platform CAIS
Investor News

Hamilton Lane invests in alts RIA platform CAIS

Next Post
VRS allocates $500m to private market funds

VRS allocates $500m to private market funds

Log In

Lost your password?

Recent

LACERA channels more money into alts

LACERA channels more money into alts

D.E. Shaw reveals strategic financing from Harbert Infrastructure

D.E. Shaw reveals strategic financing from Harbert Infrastructure

Kentucky Teachers hands out alts assignments

Kentucky Teachers hands out alts assignments

Search the AW Archives

No Result
View All Result

Download

Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Hedge Funds
  • Private Equity
  • Private Credit
  • RE/Infrastructure
  • Investor News
  • Research

Follow Us

No Result
View All Result
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard

© 2019-2022, All Rights Reserved  |  BMV Digital

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Cookie Consent
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept
Powered by CookieYes Logo